2010
DOI: 10.1016/j.parint.2010.03.006
|View full text |Cite
|
Sign up to set email alerts
|

Protective immunity against lethal anaphylactic reaction in Toxoplasma gondii-infected mice by DNA vaccination with T. gondii-derived heat shock protein 70 gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
6
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 18 publications
(7 citation statements)
references
References 33 publications
1
6
0
Order By: Relevance
“…Chitosan nanospheres were equally effective to FIA in increasing the survival time. These results are in agreement with other workers using temperature-sensitive mutant strain of T. gondii, ts-4 (Khan and Casciotti 1999), DNA vaccines (Yan et al 2011), recombinant T. gondii nucleoside triphosphatehydrolase-II (Tan et al 2011) recombinant surface tachyzoite antigen encapsulated in microparticles (Chuang et al 2013), recombinant Toxoplasma gondii protein disulfide isomerase (rTgPDI) and heat shock protein 70 gene (Kikumura et al 2010). On the contrary, both Spencer et al (2004) who used attenuated ts-4 strain with CPG as an adjuvant as well as Martin et al (2004) who used recombinant GRA4 or ROP2 vaccines with alum, reported no significant difference in survival time.…”
Section: Discussionsupporting
confidence: 92%
“…Chitosan nanospheres were equally effective to FIA in increasing the survival time. These results are in agreement with other workers using temperature-sensitive mutant strain of T. gondii, ts-4 (Khan and Casciotti 1999), DNA vaccines (Yan et al 2011), recombinant T. gondii nucleoside triphosphatehydrolase-II (Tan et al 2011) recombinant surface tachyzoite antigen encapsulated in microparticles (Chuang et al 2013), recombinant Toxoplasma gondii protein disulfide isomerase (rTgPDI) and heat shock protein 70 gene (Kikumura et al 2010). On the contrary, both Spencer et al (2004) who used attenuated ts-4 strain with CPG as an adjuvant as well as Martin et al (2004) who used recombinant GRA4 or ROP2 vaccines with alum, reported no significant difference in survival time.…”
Section: Discussionsupporting
confidence: 92%
“…9B). Clinical signs were scored according to criteria reported previously (26). The average scores Ϯ SDs for the WT and IL-17A-deficient mice were 5.81 Ϯ 0.69 and 6.46 Ϯ 0.66, Ϫ B6 mice that were uninfected (uninf.…”
Section: Resultsmentioning
confidence: 99%
“…We have developed a DNA vaccine encoding a virulent HSP70 molecule specific for tachyzoites (i.e., the pathogenic stage of T. gondii at the acute phase or at acute exacerbation of the chronic phase of infection) targeting epidermal and dermal DC against T. gondii infection (25,31,32). The T. gondii HSP70 gene vaccine is proven to induce in vivo DC activation and successive Th1 cell polarization in the dLN, and the vaccine effects persist to the chronic phase of toxoplasmosis (31).…”
Section: Discussionmentioning
confidence: 99%